Revised-international staging system is independently predictive and prognostic for early relapse (<24 months) after upfront autologous hematopoietic cell transplantation for newly diagnosed multiple myeloma.
Study #: MM16-01b
Study Status: Published
Presentation(s)
2017, ASH (Poster)
Revised international staging system is predictive and prognostic for early relapse ( <24 months) after autologous transplantation for newly diagnosed multiple myeloma.
Citation
Gopalakrishnan S, D'Souza A, Scott E, Fraser R, Davila O, Shah N, Gale RP, Kamble R, Diaz MA, Lazarus HM, Savani BN, Hildebrandt GC, Solh M, Freytes CO, Lee C, Kyle RA, Usmani SZ, Ganguly S, Assal A, Berdeja J, Kanate AS, Dhakal B, Meehan K, Kindwall-Keller T, Saad A, Locke F, Seo S, Nishihori T, Gergis U, Gasparetto C, Mark T, Nieto Y, Kumar S, Hari P.
Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2019, Apr 01: 25(4): 25(4):683-668. doi: 10.1016/j.bbmt.2018.12.141. Epub 2018, Dec 21. PMCID:PMC6453717.
PubMed
PMID: 30579965
Abstract